Position in EXEL
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$452,739
-$19,689 QoQ
Shares Held
8,321
-24.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#444
of 754 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EverSource Wealth Advisors, LLC holds $15,234,841 across 258 Biotechnology names. EXEL ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
110,689 | $6,036,977 | |
| 2 | INCY |
Incyte Corp
|
9,004 | $1,020,689 | |
| 3 | RPRX |
Royalty Pharma plc
|
13,228 | $741,689 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,357 | $674,058 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
912 | $568,663 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
16,556 | $568,200 | |
| 7 | EXEL |
Exelixis, Inc.
This page
|
8,321 | $452,739 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,146 | $324,502 |
All Filings in EXEL
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $452,739 | 8,321 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $472,428 | 11,015 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $543,967 | 12,411 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $327,052 | 7,919 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $332,141 | 7,535 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $125,120 | 3,389 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $108,854 | 3,269 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $60,253 | 2,322 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $50,038 | 2,227 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $62,954 | 2,653 | Shares | Sole | 2024-06-11 | |
| 2023-12-31 | $65,730 | 2,740 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $69,657 | 3,188 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $71,679 | 3,751 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $43,535 | 2,243 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $24,589 | 1,533 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $258,610 | 16,493 | Shares | Sole | 2022-11-07 | |
| No filing history on record for this holder in this stock. | ||||||